XOMA Royalty Corporation

News & Events

Press Releases

In The Media

1. ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of HilleVax, Inc.

   PR Newswire AUG 5, 2025 6:01 PM EDT
   ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of HilleVax, Inc. PR Newsw...
   READ ARTICLE

2. BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: HilleVax, Inc. (Nasdaq - HLVX), Steelcase Inc. (NYSE - SCS), LAVA Therapeutics N.V. (Nasdaq - LVTX), Arcadia Biosciences, Inc. (Nasdaq - RKDA)

   GlobeNewswire AUG 4, 2025 12:05 PM EDT
   BALA CYNWYD, Pa., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the ...
   READ ARTICLE

3. XOMA Royalty Enters into Agreement to Acquire LAVA Therapeutics for Between $1.16 and $1.24 Per Share in Cash, Plus a Contingent Value Right

   GlobeNewswire AUG 4, 2025 7:30 AM EDT
   EMERYVILLE, Calif. and UTRECHT, The Netherlands and PHILADELPHIA, Aug. 04, 2025 (GLOBE NEWSWIRE) ...
   READ ARTICLE

4. HilleVax Enters into a Definitive Agreement to be Acquired by XOMA Royalty for $1.95 in Cash per Share Plus a Contingent Value Right

   GlobeNewswire AUG 4, 2025 7:00 AM EDT
   BOSTON, Mass., and EMERYVILLE, Calif., Aug. 04, 2025 (GLOBE NEWSWIRE) -- HilleVax, Inc. (“...
   READ ARTICLE

5. ESSA Pharma Inc. Announces Definitive Agreement to be Acquired by XenoTherapeutics, Inc., Backed by XOMA Royalty Corporation in All-Cash Transaction

   Canada Newswire JUL 14, 2025 8:00 AM EDT
   ESSA Pharma Inc. Announces Definitive Agreement to be Acquired by XenoTherapeutics, Inc., Backed ...
   READ ARTICLE

6. ESSA Pharma Inc. Announces Definitive Agreement to be Acquired by XenoTherapeutics, Inc., Backed by XOMA Royalty Corporation in All-Cash Transaction

   PR Newswire JUL 14, 2025 8:00 AM EDT
   ESSA Pharma Inc. Announces Definitive Agreement to be Acquired by XenoTherapeutics, Inc., Backed ...
   READ ARTICLE

7. BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Carisma Therapeutics Inc. (Nasdaq - CARM), Guaranty Bancshares, Inc. (NYSE - GNTY), MRC Global Inc. (NYSE - MRC), Turnstone Biologics Corp. (Nasdaq - TSBX)

   GlobeNewswire JUN 27, 2025 11:46 AM EDT
   BALA CYNWYD, Pa., June 27, 2025 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the ...
   READ ARTICLE

8. Turnstone Biologics Corp. Enters into Agreement to be Acquired by XOMA Royalty Corporation for $0.34 in Cash Per Share Plus a Contingent Value Right

   GlobeNewswire JUN 27, 2025 7:30 AM EDT
   EMERYVILLE, Calif. and SAN DIEGO, June 27, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (&#x...
   READ ARTICLE

9. XOMA Royalty Declares Quarterly Preferred Stock Dividends

   GlobeNewswire JUN 18, 2025 7:30 AM EDT
   EMERYVILLE, Calif., June 18, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (Nasdaq: XOMA) tod...
   READ ARTICLE

10. XOMA Royalty Purchases Mezagitamab Royalty and Milestone Rights Held by BioInvent International for up to USD $30 Million

    GlobeNewswire MAY 27, 2025 8:01 AM EDT
    EMERYVILLE, Calif. and LUND, Sweden, May 27, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (N...
    READ ARTICLE